A prospective, blinded trial of touch prep analysis versus frozen section for intraoperative evaluation of sentinel lymph nodes in breast cancer

Annals of Surgical Oncology

Volumn 15, Issue 7, 2008, Pages 2006-2011

  Vanderveen, Kimberly A ^a   Ramsamooj, Rajendra ^a   Bold, Richard J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast Cancer; Frozen section; Intraoperative pathologic evaluation; Sentinel lymph node biopsy; Touch imprint cytology

Indexed keywords

EOSIN; HEMATOXYLIN; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE CARE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SINGLE BLIND PROCEDURE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CYTODIAGNOSIS; FEMALE; FROZEN SECTIONS; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SINGLE-BLIND METHOD;

EID: 46149099553     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9944-8     Document Type: Article

References (43)

1. Hutchinson JR, Chagpar AB, Scoggins CR, et al. Surgeon and community factors affecting breast cancer sentinel lymph node biopsy. Am J Surg 2005; 190:903-6
2. Lucci A Jr, Kelemen PR, Miller C 3rd, et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 2001; 192:453-8
3. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000; 18:2560-6
4. Davis KG, Schriver JP, Waddell B. Implementation of sentinel lymph node biopsy for breast cancer by surgeons in the Department of Defense. Am J Surg 2002; 184:94-6
5. Maggard MA, Lane KE, O'Connell JB, et al. Beyond the clinical trials: how often is sentinel lymph node biopsy performed for breast cancer? Ann Surg Oncol 2005; 12:41-7
6. Conn CA, McMasters KM, Edwards MJ, et al. Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in Kentucky. Breast J 2005; 11:231-5
7. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 1991; 265:391-5
8. Edge SB, Niland JC, Bookman MA, et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst 2003; 95:1514-21
9. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2003; 94:2542-51
10. American Society of Breast Surgeons (October 2003). Consensus statement on guidelines for performance of sentinel lymphadenectomy for breast cancer. Available: http://www.breastsurgeons.org/officialstmts/sentinel.shtml [accessed: September 23, 2007]
11. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer-v 2.2006. Available: http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf [accessed: September 23, 2007]
12. Singh-Ranger G, Mokbel K. The sentinel node biopsy is a new standard of care for patients with early breast cancer. Int J Fertil Womens Med 2004; 49:225-7
13. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703-20
14. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2002; 88:608-14
15. Peintinger F, Reitsamer R, Stranzl H, et al. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003; 89:648-52
16. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003; 29:341-50
17. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006; 13:491-500
18. Cody HS, Borgen PI, Tan LK. Redefining prognosis in node-negative breast cancer: can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy? Ann Surg Oncol 2004; 11:227S-30S
19. Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997; 80:1188-97
20. Bonnema J, van de Velde CJ. Sentinel lymph node biopsy in breast cancer. Ann Oncol 2002; 13:1531-7
21. Kane JM, Edge SB, Winston JS, et al. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann of Surg Oncol 2001; 8:361-7
22. Menes TS, Tartter PI, Mariachi H, et al. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol 2003; 10:1166-70
23. Shiver SA, Creager AJ, Shen P, et al. Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. Am J Surg 2002; 184:424-7
24. Henry-Tillman RS, Korourian S, Rubio IT, et al. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann Surg Oncol 2002; 9:333-9
25. Ratanawichitrasin A, Biscotti CV, Levy L, et al. Touch imprint cytological analysis of sentinel lymph nodes for breast carcinoma staging. Am J Clin Pathol 1999; 112:627-34
26. Van Diest PJ, Torrenga H, Borgstein PJ, et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopath 1999; 35:14-8
27. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349:1864-7
28. Viale G, Bosari S, Mazzarol G, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999; 85:243-8
29. Aihara T, Munakata S, Morino H, et al. Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann Surg Onc 2004; 11:747-50
30. Motomura K, Inaji H, Komoike Y, et al. Intraoperative sentinel lymph node examination by touch imprint cytology and frozen sectioning during breast surgery. BMJ 2000; 87:597-601
31. Hughs SJ, Xi L, Raja S, et al. A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg 2006; 243:389-98
32. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007; 13:4807-16
33. Bold RJ, Schleiman M, Fahy BN. Sentinel lymph node biopsy for breast cancer. Cancer Biother Radiopharm 2001; 16:347-57
34. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002
35. Mullenix PS, Carter PL, Martin MJ, et al. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer. Am J Surg 2003; 185:420-4
36. Karamlou T, Johnson NM, Chan B, et al. Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer. Am J Surg 2003; 185:425-8
37. Zgajnar J, Frkovic-Grazio S, Besic N, et al. Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients-results of a large series. J Surg Oncol 2004; 85:82-6
38. Pugliese MS, Tickman R, Wang NP, et al. The utility of intraoperative evaluation of sentinel lymph nodes in breast cancer. Ann Surg Oncol 2007; 14:1024-30
39. Genta F, Zannon E, Camanni M, et al. Cost/Accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node. World J Surg 2007; 31:1155-63
40. Houvenaeghel G, Nos C, Mignotte H, et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement-Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 2006; 24:1814-22
41. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003; 10:1140-51
42. Cserni G. Comparison of different validation studies on the use of the Memorial-Sloan Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node-positive breast cancer patients. Am J Surg 2006; 192:484-7
43. Park J, Fey JV, Naik AM, et al. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 2007; 245:462-8